Inhaled aprotenin 200 KIU/mL clinical trials

APROTININ TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME: A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III TRIAL

This study is looking into a treatment called aprotonin for a serious lung condition called Acute Respiratory Distress Syndrome (ARDS). It compares aprotonin to a dummy treatment to see if it helps patients breathe better without a ventilator.